Characterization of Residual Impurities in Gene Therapy Drug Products

With the increase and complexity of the global supply chain, both the pharmaceutical cold chain and temperature-controlled shipping for the food and beverage industry have seen substantial growth over the last few years. It is no coincidence that the food industry is now beginning to look to the pharmaceutical supply chain for guidance on best practices, as the need for stricter standardization and controls has emerged.

Gain a better understanding of quality health care and improved patient outcomes based on the quality of care. Health care is quickly becoming a commodity. The increased focus on quality by CMS and other payer sources has driven the need to create effective strategies to control costs. One such strategy is reducing preventable readmissions. Hospitals are keenly aware of the cost of readmissions, both in penalties from CMS and in their reputation as centers for quality and improved patient outcomes. The purpose of this information is to equip the user with the tools to identify those patients at risk, to intervene when necessary, to disseminate to their staff, and to ensure that lasting change will occur. This information is an intermediate level course designed for mid to upper-level hospital administrators. This course is ideal for the hands-on manager to assess and implement a hospital-wide program aimed at reducing the number of readmissions.

Speed and quality are key in pharmaceutical manufacturing. How can your equipment add value to your production process? Join the Lonza team to discover how the new Lonza Engine™ equipment portfolio is designed to support bioavailability enhancement, encapsulation and early-phase clinical development technologies.

The goal of medical education is to produce a physician workforce capable of delivering high-quality care to our patients and communities.